Near-infrared fluorescent imaging of metastatic ovarian cancer using folate receptor-targeted high-density lipoprotein nanocarriers.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nanomedicine

• Publication date

  2013-06-04

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.2217/nnm.12.137PMID 23067398PMCID PMC3652907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles

  2012cited by this paper
• Lipoprotein-Inspired Nanoparticles for Cancer Theranostics

  2011cited by this paper
• Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

  2011cited by this paper
• The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Lipoprotein‐Based Nanoplatforms for Cancer Molecular Imaging

  2011cited by this paper
• Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

  2011cited by this paper
• Mechanisms of membrane transport of folates into cells and across epithelia.

  2011cited by this paper
• Antitumor Effects of a Human Dimeric Antibody Fragment 131I-AFRA-DFM5.3 in a Mouse Model for Ovarian Cancer

  2011cited by this paper
• Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis.

  2011cited by this paper
• Evaluation of bacteriochlorophyll-reconstituted low-density lipoprotein nanoparticles for photodynamic therapy efficacy in vivo.

  2011cited by this paper
• Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent.

  2010cited by this paper
• In vitro assessment of poly-iodinated triglyceride reconstituted low-density lipoprotein: initial steps toward CT molecular imaging.

  2010cited by this paper
• Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles.

  2010cited by this paper
• Intracellular drug delivery by genetically engineered high-density lipoprotein nanoparticles.

  2010cited by this paper
• Uptake of synthetic Low Density Lipoprotein by leukemic stem cells--a potential stem cell targeted drug delivery strategy.

  2010cited by this paper
• Drug Delivery Systems for Intraperitoneal Therapy

  2010cited by this paper
• Use of 99mTc-EC20 (a folate-targeted imaging agent) to predict response to therapy with EC145 (folate-targeted therapy) in advanced ovarian cancer.

  2010cited by this paper
• RGD peptide functionalized and reconstituted high‐density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe

  2010cited by this paper
• Nanoparticles for tumor-specific intracellular drug delivery

  2009cited by this paper
• Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

  2009cited by this paper
• Synthesis and evaluation of a stable bacteriochlorophyll-analog and its incorporation into high-density lipoprotein nanoparticles for tumor imaging.

  2009cited by this paper
• Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

  2008cited by this paper
• Folate receptor alpha as a tumor target in epithelial ovarian cancer.

  2008cited by this paper
• Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligands

  2008cited by this paper
• Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes

  2008cited by this paper
• Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel

  2008cited by this paper
• In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications.

  2007cited by this paper
• Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo.

  2007cited by this paper
• Enhanced Cancer-Targeted Delivery Using Engineered High-density Lipoprotein-Based Nanocarriers

  2007cited by this paper
• Phase I Trial of Intraperitoneal Gemcitabine in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity

  2007cited by this paper
• Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B Published, JLR Papers in Press, November 28, 2005.

  2006cited by this paper
• Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption.

  2006cited by this paper
• Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials

  2006cited by this paper
• Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay.

  2005cited by this paper
• High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.

  2005cited by this paper
• Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

  2005cited by this paper
• Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.

  2004cited by this paper
• Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.

  2003cited by this paper
• Ovarian cancer: strategies for overcoming resistance to chemotherapy

  2003cited by this paper
• A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins.

  2003cited by this paper
• Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.

  2003cited by this paper
• Optical imaging of metastatic tumors using a folate-targeted fluorescent probe.

  2003cited by this paper
• Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

  2003cited by this paper
• Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells.

  2002cited by this paper
• Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting.

  2001cited by this paper
• Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer.

  2001cited by this paper
• Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis.

  2001cited by this paper
• Development of a syngeneic mouse model for events related to ovarian cancer.

  2000cited by this paper
• Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI.

  1999cited by this paper
• Folate receptors as potential therapeutic targets in choroid plexus tumors of SV40 transgenic mice

  1997cited by this paper
• Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure.

  1997cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles.

  1994cited by this paper
• Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells.

  1993cited by this paper
• Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

  1992cited by this paper
• Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.

  1992cited by this paper
• Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.

  1992cited by this paper
• Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

  1991cited by this paper
• Improved prognosis of ovarian cancer in The Netherlands during the period 1975-1985: a registry-based study.

  1991cited by this paper
• Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.

  1990cited by this paper
• Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide.

  1987cited by this paper
• Synthetic high density lipoprotein particles. Application to studies of the apoprotein specificity for selective uptake of cholesterol esters.

  1987cited by this paper
• Intraperitoneal chemotherapy with melphalan.

  1984cited by this paper
• Plasma lipoproteins: apolipoprotein structure and function.

  1984cited by this paper
• Local and systemic toxicity resulting from large-volume ip administration of doxorubicin in the rat.

  1982cited by this paper
• Structure of human serum lipoproteins inferred from compositional analysis.

  1977cited by this paper
• Forms of human serum high density lipoprotein protein.

  1966cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Advances in hybrid hydrogel design for biomedical applications: innovations in drug delivery and tissue engineering for gynecological cancers

  2025cites this paper
• HDL and LDL-bioinspired nanocarriers in acellular targeted delivery of Icariin for cardiac repair post myocardial infarction.

  2025cites this paper
• Recent advances in nanostructure-enhanced optical assays focused on luminescence-based biosensors for cancer biomarkers

  2024cites this paper
• Nanomedicine-based targeting delivery systems for peritoneal cavity localized therapy: A promising treatment of ovarian cancer and its peritoneal metastasis

  2024cites this paper
• Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery

  2024cites this paper
• The Application of Nanoparticle-Based Imaging and Phototherapy for Female Reproductive Organs Diseases.

  2023cites this paper
• Bionanoparticles in cancer imaging, diagnosis, and treatment

  2022cites this paper
• Erythrocyte-Derived Nanoparticles with Folate Functionalization for Near Infrared Pulsed Laser-Mediated Photo-Chemotherapy of Tumors

  2022cites this paper
• Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment.

  2022cites this paper
• Gemcitabine lipid prodrug nanoparticles: switching the lipid moiety and changing the fate in the bloodstream.

  2021cites this paper
• Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures.

  2021cites this paper
• Near-Infrared Fluorescent Agent for In Vitro Screening of Endometrial Cancer and Precancerous Lesions

  2021cites this paper
• A Novel Biocompatible Nanoprobe Based on Lipoproteins for Breast Cancer Cell Imaging

  2020cites this paper
• New nanoprobe for breast cancer cell imaging based on low-density lipoprotein

  2020cites this paper
• A systematic review of the biodistribution of biomimetic high-density lipoproteins in mice.

  2020cites this paper
• A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer.

  2020cites this paper
• Lipid profile and risk of ovarian tumours: a meta-analysis

  2020cites this paper
• Folate Receptor and Targeting Strategies

  2019cites this paper
• Stimuli-Responsive Nanoscale Hydrogels For The Improved Delivery Of Chemotherapeutic Agents

  2019cites this paper
• Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research

  2019cites this paper
• Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery

  2018cites this paper
• Heat-induced-radiolabeling and click chemistry: A powerful combination for generating multifunctional nanomaterials

  2017cites this paper
• Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.

  2017cites this paper
• High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

  2016cites this paper
• Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

  2016cites this paper
• Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent

  2016cites this paper
• Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.

  2016cites this paper
• Synthetic high-density lipoprotein-like nanoparticles for cancer therapy

  2015influential citation
• Recent Advances in Tumor Targeting Approaches

  2015cites this paper
• Virus-resembling nano-structures for near infrared fluorescence imaging of ovarian cancer HER2 receptors

  2015cites this paper
• Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging

  2015cites this paper
• Cancer active targeting by nanoparticles: a comprehensive review of literature

  2015cites this paper
• Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

  2015cites this paper
• Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

  2014cites this paper
• Folate/NIR 797-Conjugated Albumin Magnetic Nanospheres: Synthesis, Characterisation, and In Vitro and In Vivo Targeting Evaluation

  2014cites this paper
• Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells

  2014cites this paper
• Title Functionalized polymeric nanoparticles loaded with indocyanine green as theranostic materials for targeted molecular near infrared fluorescence imaging and photothermal destruction of ovarian cancer cells

  2014cites this paper
• Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.

  2014cites this paper
• Ligand-coupled lipoprotein for ovarian cancer-specific drug delivery.

  2013cites this paper
• Structures of a novel phosphoric triamide and its organotin(IV) complex

  2013cites this paper